Results 71 to 80 of about 14,162 (232)

[Artículo traducido] Alteración de la homeostasis cutánea en lesiones de hidradenitis supurativa, un estudio comparativo

Actas Dermo-Sifiliográficas
Resumen: Introducción: La hidradenitis supurativa (HS) es una enfermedad crónica de la piel cuyo impacto sobre la homeostasis cutánea no ha sido adecuadamente estudiado en la actualidad.
A. Soto-Moreno, N. Delgado-Moya, M. Sánchez-Díaz, S. Arias-Santiago, A. Molina-Leyva   +4 more
doaj   +1 more source

An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis [PDF]

, 2019
Paola Maura Tricarico, Michele Boniotto, Giovanni Genovese, Christos C. Zouboulis, Angelo Valerio Marzano, Sérgio Crovella   +5 more
openalex   +1 more source

43019 Spesolimab for hidradenitis suppurativa: A proof-of-concept study [PDF]

, 2023
Afsáneh Alavi, Errol P. Prens, Alexa B. Kimball, James G. Krueger, Sutirtha Mukhopadhyay, Hui Wang, Nathalie Ivanoff, Ana C. Hernandez Daly, Christos C. Zouboulis   +8 more
openalex   +1 more source

Efficacy and safety of biologics for hidradenitis suppurativa: A network meta‐analysis of phase III trials

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Data from 2731 patients with hidradenitis suppurativa (HS) treated with biologics for 12–16 weeks in phase III randomized controlled trials (RCT) were included in a network meta‐analysis (NMA). Adalimumab showed the highest efficacy in achieving a clinical HS response 50 (HiSCR50) and the lowest incidence of adverse events (AE).
Laura Calabrese, Alessandra Cartocci, Pietro Rubegni, Lars E. French, Benjamin Kendziora   +4 more
wiley   +1 more source

Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Forty‐three HS specialists from 22 European countries reported adherence to HS guidelines and use of antibiotics before biologics despite limited efficacy and rapid relapse (49% within 1–3 months). Seventy‐nine per cent supported short‐term biologics for severe Hurley I disease.
Georgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova, Falk G. Bechara, Farida Benhadou, Joana Cabete, Raffaele Dante Caposiena Caro, Giovanni Damiani, Maia Delage Toriel, Veronique Del Marmol, Valentina Dini, Evangelos J. Giamarellos‐Bourboulis, Katalin Glasenhardt, Philippe Guillem, Ariela Hafner, Evgeniya Hristakieva, John R. Ingram, Vaiva Jarienè, Gregor B. E. Jemec, Niamh Kearney, Brian Kirby, Natalia Kirsten, Piotr K. Krajewski, Vesta Kucinskiene, Aikaterini I. Liakou, Flavia Manzo Margiotta, Angelo V. Marzano, Antonio Martorell, Lukasz Matusiak, Dillon Mintoff, Alejandro Molina Leyva, Francesca Prignano, Tadas Raudonis, Hans Christian Ring, Marco Romanelli, Samed Şahin, Ditte M. L. Saunte, Linnea Thorlacius, Thrasyvoulos Tzellos, Hessel H. Van Der Zee, Kelsey Van Straalen, Christos C. Zouboulis   +41 more
wiley   +1 more source

https://researchopenworld.com/genetics-of-hidradenitis-suppurativa/# [PDF]

, 2020
Airong Li, Rudolph E. Tanzi, A Garg, J Kirby, J Lavian, G Lin, A Strunk, J Wipperman, D Bragg, B Litzner, A Alikhan, P Lynch, D Eisen, L Prens, J Huizinga, I Janse, B Horvath, L Lasko, C Post, S Kathju, S Reddy, A Strunk, A Garg, G Yosipovitch, A Devore, Dawn, P Acharya, M Mathur, A Shah, R Alhusayen, S Amini-Nik, R Vankeviciute, B Polozovaite, J Trapikas, T Raudonis, J Grigaitiene, F Choi, L Lehmer, C Ekelem, N Mesinkovska, A Dempsey, M Butt, J Kirby, S Reddy, Lav Orenstein, A Strunk, A Garg, I Miller, O Ahlehoff, G Vinding, H Rytgaard, U Mogensen, K Kridin, M Shani, Y Schonmann, S Fisher, G Shalom, J Ingram, A Pink, M Simpson, N Desai, D Dafou, A Hills, C Li, M Jiang, D Shen, H Xu, H Wang, S Zhang, J Meng, M Jiang, J Zhao, M Liu, J Davis, K Idler, N Mostafa, M Okun, B Wang, W Yang, Wen Sun, J Su, B, S Chen, P Mattei, J You, N Sobreira, G Hinds, X Xiao, Y He, C Li, X Zhang, H Xu, S Ma, Y Yu, G Yu, F Zhang, S Miskinyte, A Nassif, F Merabtene, M Ungeheuer   +99 more
openalex   +1 more source

Bimekizumab plus topical photochemotherapy effective in palmoplantar pustulosis in a patient with hidradenitis suppurativa

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Neda Cramer, Johannes Mohr, Michael P. Schön, Rotraut Mössner   +3 more
wiley   +1 more source

Hair follicle stem cell fate supports distinct clinical endotypes in hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Hair follicles (HFs) were extracted from skin biopsies. From these, original sequencing data were obtained and integrated with two independent studies to build a HF single‐cell transcriptomic atlas. It enabled delineating the fate of HF stem cells.
Audrey Onfroy, Francette Jean‐Louis, Philippe Le Corvoisier, Fanny Coulpier, Kévin Muret, Eric Bonnet, Raphaele Arrouasse, Caroline Boucle, Salwa Abid, Emilie Sbidian, Christina Bergqvist, Pierre Wolkenstein, Véronique Godot, Jean‐François Deleuze, Yves Lévy, Piotr Topilko, Etienne Audureau, Sophie Hue   +17 more
wiley   +1 more source

The concomitant occurrence of hidradenitis suppurativa and Fournier’s gangrene

European Journal of Case Reports in Internal Medicine
Background: Fournier’s gangrene represents a life-threatening necrotising infection affecting the perineal region, while hidradenitis suppurativa is characterised by a chronic inflammatory skin condition. The simultaneous occurrence of both conditions is
Georges Khattar, Elie Bou Sanayeh, Marina Makram, Hussein Rabah, Saif Abu Baker, Salman Khan, Catherine Hong   +6 more
doaj   +1 more source

912 Gut microbiome diversity is reduced in patients with hidradenitis suppurativa [PDF]

, 2023
W. Wyant, M. Collard, N. Grbic, J. Lam, S. Kam, H. Mumber, R. Alani   +6 more
openalex   +1 more source